top of page
Starting August 1, 2024, Quickarrays, Inc. will be providing all products and services in place of Pantomics Inc.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
Hermatopathology
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
EMC962
Endometrial cancer tissue array, set 2, non-overlapping with EMC962, 96 cores, 48 cases from normal, premalignant and cancer tissues with progressive grades and TNM stages in duplicates.
Specification
Data Sheet
TNM Grading
Downloads
Price
Size
Availability
$298
1 slide
In-Stock
A | |
B | |
C | |
D | |
E | |
F | |
G | |
H | |
TNM Classification : Endometrium carcinoma
T- Primary tumor
TX - Primary tumor cannot be assessed
TO - No evidence of primary tumor
Tis - Carcinoma in situ (preinvasive carcinoma)
T1 - Tumor confined to corpus uteri
T1a - Tumor limited to endometrium
T1 b - Tumor invades up to less than one half of myometrium
T1c - Tumor invades to more than one half of myometrium
T2 - Tumor invades cervix but does not extend beyond uterus
T2a - Endocervical glandular involvement only
T2b - Cervical stromal invasion
T3 (and/or N1) - Local or regional spread as specified below
T3a - Tumor invlove serosa and/or adnexa and/or cancer cells in ascites or peritoneal washing
T3b - Vaginal involvement
(N1) - Metastasis to pelvic and/or para-aortic lymph nodes
T4 - Tumor invades bladder mucosa and/or bowel mucosa
N - Regional lymph nodes
NX - Regional lymph nodes cannot be assessed
NO - No regional lymph node metastasis N1 - Regional lymph node metastasis
N1a - Metastasis in a single regional lymph node
N1b - Metastasis in multiple regional lymph nodes
M - Distant metastasis
MX - Distant metastasis cannot be assessed
MO - No distant metastasis
M1 - Distant metastasis
Human
48
96
1.5mm
4um
8
12
Paraffin
Notes:
All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.
Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in evolution and progression of endometrium cancers.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|
A01 | F | 44 | Uterus, endometrium | Normal | |||
A02 | F | 37 | Uterus, endometrium | Normal | |||
A03 | F | 40 | Uterus, endometrium | Normal | |||
A04 | F | 45 | Uterus, endometrium | Endometrium of proliferative phase | |||
A05 | F | 49 | Uterus, endometrium | Endometrium of proliferative phase | |||
A06 | F | 72 | Uterus, endometrium | Endometrium of proliferative phase | |||
A07 | F | 34 | Uterus, endometrium | Endometrium of proliferative phase | |||
A08 | F | 56 | Uterus, endometrium | Simple hyperplasia | |||
A09 | F | 47 | Uterus, endometrium | Simple hyperplasia | |||
A10 | F | 40 | Uterus, endometrium | Endometrium | |||
A11 | F | 52 | Uterus, endometrium | Endometrium | |||
A12 | F | 40 | Uterus, endometrium | Polyps | |||
B01 | F | 44 | Uterus, endometrium | Normal | |||
B02 | F | 37 | Uterus, endometrium | Normal | |||
B03 | F | 40 | Uterus, endometrium | Normal | |||
B04 | F | 45 | Uterus, endometrium | Endometrium of proliferative phase | |||
B05 | F | 49 | Uterus, endometrium | Endometrium of proliferative phase | |||
B06 | F | 72 | Uterus, endometrium | Endometrium of proliferative phase | |||
B07 | F | 34 | Uterus, endometrium | Endometrium of proliferative phase | |||
B08 | F | 56 | Uterus, endometrium | Simple hyperplasia | |||
B09 | F | 47 | Uterus, endometrium | Simple hyperplasia | |||
B10 | F | 40 | Uterus, endometrium | Endometrium | |||
B11 | F | 52 | Uterus, endometrium | Endometrium | |||
B12 | F | 40 | Uterus, endometrium | Polyps | |||
C01 | F | 43 | Uterus, endometrium | Adenocarcinoma | I | T1N0M0 | |
C02 | F | 39 | Uterus, endometrium | Adenocarcinoma | I | T2N0M0 | |
C03 | F | 42 | Uterus, endometrium | Adenocarcinoma | I | T1N0M0 | |
C04 | F | 65 | Uterus, endometrium | Adenocarcinoma | I | T1N0M0 | |
C05 | F | 53 | Uterus, endometrium | Adenocarcinoma | I~II | T1N0M0 | |
C06 | F | 53 | Uterus, endometrium | Adenocarcinoma | I~II | T1N0M0 | |
C07 | F | 60 | Uterus, endometrium | Adenocarcinoma | I~II | T1N0M0 | |
C08 | F | 53 | Uterus, endometrium | Adenocarcinoma | I~II | T1N0M0 | |
C09 | F | 49 | Uterus, endometrium | Adenocarcinoma | I~II | T1N0M0 | |
C10 | F | 33 | Uterus, endometrium | Adenocarcinoma | I~II | T2N0M0 | |
C11 | F | 60 | Uterus, endometrium | Adenocarcinoma | I~II | T1N0M0 | |
C12 | F | 48 | Uterus, endometrium | Adenocarcinoma | II | T1N0M0 | |
D01 | F | 43 | Uterus, endometrium | Adenocarcinoma | I | T1N0M0 | |
D02 | F | 39 | Uterus, endometrium | Adenocarcinoma | I | T2N0M0 | |
D03 | F | 42 | Uterus, endometrium | Adenocarcinoma | I | T1N0M0 | |
D04 | F | 65 | Uterus, endometrium | Adenocarcinoma | I | T1N0M0 | |
D05 | F | 53 | Uterus, endometrium | Adenocarcinoma | I~II | T1N0M0 | |
D06 | F | 53 | Uterus, endometrium | Adenocarcinoma | I~II | T1N0M0 | |
D07 | F | 60 | Uterus, endometrium | Adenocarcinoma | I~II | T1N0M0 | |
D08 | F | 53 | Uterus, endometrium | Adenocarcinoma | I~II | T1N0M0 | |
D09 | F | 49 | Uterus, endometrium | Adenocarcinoma | I~II | T1N0M0 | |
D10 | F | 33 | Uterus, endometrium | Adenocarcinoma | I~II | T2N0M0 | |
D11 | F | 60 | Uterus, endometrium | Adenocarcinoma | I~II | T1N0M0 | |
D12 | F | 48 | Uterus, endometrium | Adenocarcinoma | II | T1N0M0 | |
E01 | F | 53 | Uterus, endometrium | Adenocarcinoma | II | T2N0M0 | |
E02 | F | 54 | Uterus, endometrium | Adenocarcinoma | II | T1N0M0 | |
E03 | F | 53 | Uterus, endometrium | Adenocarcinoma | II | T1N0M0 | |
E04 | F | 68 | Uterus, endometrium | Adenocarcinoma | II | T1N0M0 | |
E05 | F | 56 | Uterus, endometrium | Adenocarcinoma | II | T2N0M0 | |
E06 | F | 43 | Uterus, endometrium | Adenocarcinoma | II | T1N0M0 | |
E07 | F | 40 | Uterus, endometrium | Adenocarcinoma | II | T2N0M0 | |
E08 | F | 58 | Uterus, endometrium | Adenocarcinoma | II | T1N0M0 | |
E09 | F | 66 | Uterus, endometrium | Adenocarcinoma | II | T2N0M0 | |
E10 | F | 57 | Uterus, endometrium | Adenocarcinoma | II~III | T1N0M0 | |
E11 | F | 43 | Uterus, endometrium | Adenocarcinoma | II~III | T2N0M0 | |
E12 | F | 48 | Uterus, endometrium | Adenocarcinoma | II~III | T1N0M0 | |
F01 | F | 53 | Uterus, endometrium | Adenocarcinoma | II | T2N0M0 | |
F02 | F | 54 | Uterus, endometrium | Adenocarcinoma | II | T1N0M0 | |
F03 | F | 53 | Uterus, endometrium | Adenocarcinoma | II | T1N0M0 | |
F04 | F | 68 | Uterus, endometrium | Adenocarcinoma | II | T1N0M0 | |
F05 | F | 56 | Uterus, endometrium | Adenocarcinoma | II | T2N0M0 | |
F06 | F | 43 | Uterus, endometrium | Adenocarcinoma | II | T1N0M0 | |
F07 | F | 40 | Uterus, endometrium | Adenocarcinoma | II | T2N0M0 | |
F08 | F | 58 | Uterus, endometrium | Adenocarcinoma | II | T1N0M0 | |
F09 | F | 66 | Uterus, endometrium | Adenocarcinoma | II | T2N0M0 | |
F10 | F | 57 | Uterus, endometrium | Adenocarcinoma | II~III | T1N0M0 | |
F11 | F | 43 | Uterus, endometrium | Adenocarcinoma | II~III | T2N0M0 | |
F12 | F | 48 | Uterus, endometrium | Adenocarcinoma | II~III | T1N0M0 | |
G01 | F | 49 | Uterus, endometrium | Adenocarcinoma | II~III | T2N0M0 | |
G02 | F | 53 | Uterus, endometrium | Adenocarcinoma | III | T2N1M0 | |
G03 | F | 53 | Uterus, endometrium | Adenocarcinoma | III | T1N0M0 | |
G04 | F | 51 | Uterus, endometrium | Adenocarcinoma | III | T1N0M0 | |
G05 | F | 46 | Uterus, endometrium | Adenocarcinoma | III | T1N0M0 | |
G06 | F | 53 | Uterus, endometrium | Adenocarcinoma | III | T3N0M0 | |
G07 | F | 67 | Uterus, endometrium | Adenocarcinoma | III | T2N0M0 | |
G08 | F | 52 | Uterus, endometrium | Adenocarcinoma | III | T1N0M0 | |
G09 | F | 60 | Uterus, endometrium | Adenocarcinoma | III | T3N0M0 | |
G10 | F | 36 | Uterus, endometrium | Undifferentiated carcinoma | T1N0M0 | ||
G11 | F | 58 | Uterus, endometrium | Squamous cell carcinoma | II~III | T1N0M0 | |
G12 | F | 44 | Uterus, endometrium | Stromal sarcoma | |||
H01 | F | 49 | Uterus, endometrium | Adenocarcinoma | II~III | T2N0M0 | |
H02 | F | 53 | Uterus, endometrium | Adenocarcinoma | III | T2N1M0 | |
H03 | F | 53 | Uterus, endometrium | Adenocarcinoma | III | T1N0M0 | |
H04 | F | 51 | Uterus, endometrium | Adenocarcinoma | III | T1N0M0 | |
H05 | F | 46 | Uterus, endometrium | Adenocarcinoma | III | T1N0M0 | |
H06 | F | 53 | Uterus, endometrium | Adenocarcinoma | III | T3N0M0 | |
H07 | F | 67 | Uterus, endometrium | Adenocarcinoma | III | T2N0M0 | |
H08 | F | 52 | Uterus, endometrium | Adenocarcinoma | III | T1N0M0 | |
H09 | F | 60 | Uterus, endometrium | Adenocarcinoma | III | T3N0M0 | |
H10 | F | 36 | Uterus, endometrium | Undifferentiated carcinoma | T1N0M0 | ||
H11 | F | 58 | Uterus, endometrium | Squamous cell carcinoma | II~III | T1N0M0 | |
H12 | F | 44 | Uterus, endometrium | Stromal sarcoma | |||
null |
bottom of page